In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Latest From BioNTech US

US Price for Pfizer COVID Vaccine Includes Company Distribution Efforts Directed By DOD, CDC

Pfizer is responsible for distribution work as part of its $1.95bn agreement with the US government for its COVID-19 vaccine. The CDC and Defense Department will lead a joint vaccination effort, senior adminsitration officals said, raising concerns of public health experts who say DOD support will be useful for the unprecented vaccination campaign, but public health leadership will be critical for public buy-in.

Coronavirus COVID-19 Vaccines

Moderna’s COVID-19 Vaccine To Get Real-Time Data Assessment By US FDA

Commissioner Hahn says FDA will see data as it is compiled to speed review; enrollment criteria raises some eyebrows since Moderna plans to exclude patients with known history of SARS-CoV-2 infection from Phase III. The agency’s guidance on COVID-19 vaccine trials says that such exclusions are not necessary since screening is unlikely when a product would be delivered post-market.

Coronavirus COVID-19 Vaccines

Pfizer’s Go-It-Alone Approach Nets $1.95bn COVID Vaccine Order From US Government

Supply agreement with the Health and Human Services Department and the Department of Defense reflects a profitable per dose price of $19.50 for an initial batch of 100 million doses of the vaccine candidate, pending FDA authorization or approval.

Coronavirus COVID-19 Pricing Strategies

Regulators Want Tough Criteria For COVID-19 Vaccine Efficacy Trials

The International Coalition of Medicines Regulatory Authorities have sketched out the criteria that should be met before candidate coronavirus vaccines can proceed into late-stage trials, and agreed on how to design the studies and who should be included.

International Coronavirus COVID-19
See All

Company Information

  • Industry
  • Digital Health
  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Drug Discovery Tools
      • Bioinformatics
  • Other Names / Subsidiaries
    • Neon Therapeutics, Inc.
UsernamePublicRestriction

Register